Venmax Drugs And Pharmaceuticals Ltd — Quarter and year ended 31st March 2026
| Particulars | Quarter ended | Year Ended |
|---|---|---|
| 31/03/2026 (Audited) | 31/12/2025 (Unaudited) | |
| I Income | ||
| Revenue from operations | 394.39 | 155.23 |
| Other income | 9.21 | 6.83 |
| Total Revenue (I+II) | 403.60 | 162.06 |
| II Expenses | ||
| Cost of materials consumed | – | – |
| Purchases of Stock-in-Trade | 306.32 | 145.29 |
| Change of Inventory | 57.27 | (4.25) |
| Employee benefits expense | 5.43 | 3.47 |
| Finance costs | – | – |
| Depreciation and amortization expense | 0.10 | 0.10 |
| Other expenses | 24.05 | 13.16 |
| Total expenses | 393.16 | 157.77 |
| III | ||
| Profit before Exceptional items and tax | 10.44 | 4.29 |
| Exceptional Items | – | – |
| Profit / (Loss) before tax | 10.44 | 4.29 |
| IV Tax expense: | ||
| – Current tax | (0.28) | 1.08 |
| – Deferred tax | (0.00) | (0.00) |
| Profit/(loss) for the period from continuing operations | (0.28) | 1.08 |
| Profit/(loss) from discontinued operations | – | – |
| Tax expense of discontinued operations | – | – |
| Profit/(loss) from Discontinued operations (After tax) | – | – |
| V Profit/(loss) for the year | 10.72 | 3.21 |
| Particulars | Notes | As at 31st March 2026, Audited | As at 31st March 2025, Audited |
|---|---|---|---|
| I. ASSETS | |||
| (1) Non-Current Assets | |||
| (a) Property, Plant and Equipment | 3 | 3.65 | 4.05 |
| (b) Capital Work-In-Progress | |||
| (c) Intangible Assets | |||
| (d) Financial Assets | |||
| (i) Non-Current Investments | |||
| (ii) Trade and Other Receivables | |||
| (iii) Long Term Loans and Advances | |||
| (d) Deferred Tax Assets (Net) | |||
| (e) Other Non-Current Assets | |||
| Non-Current Assets | 3.65 | 4.05 | |
| (2) Current Assets | |||
| (a) Inventories | 4 | 99.88 | 5.75 |
| (b) Financial Assets | |||
| (i) Investments | 5 | ||
| (ii) Trade and Other Receivables | 5 | 143.00 | 95.26 |
| (iii) Cash and Cash Equivalents | 6 | 122.36 | 248.24 |
| (iv) Other Financial Assets | 7 | 734.97 | 161.00 |
| (c) Other Current Assets | 8 | 516.14 | 2.67 |
| Current Assets | 1616.36 | 512.91 | |
| Total Assets | 1620.02 | 516.96 | |
| I. EQUITY AND LIABILITIES | |||
| (1) Equity | |||
| (a) Share Capital | 9 | 1158.29 | 523.89 |
| (b) Other Equity | 10 | 253.33 | (82.70) |
| Equity | 1411.62 | 441.19 | |
| (2) Non-Current Liabilities | |||
| (a) Financial Liabilities | |||
| (i) Long Term Borrowings | 11(a) | 4.96 | 4.96 |
| Description | Note | As on 31.03.2026 | As on 31.03.2025 |
|---|---|---|---|
| (b) Provisions | |||
| (c) Deferred Tax Liabilities (Net) | 12 | 0.10 | 0.10 |
| (d) Other Non-current Liabilities | |||
| Non-Current Liabilities | 5.06 | 5.06 | |
| (3) Current Liabilities | |||
| (a) Financial Liabilities | |||
| – Short term Borrowings | 11(b) | 28.13 | 0.00 |
| – Other Financial Liabilities | 13 | 1.81 | 0.85 |
| (i) Trade Payables | |||
| Micro and small enterprises | |||
| Other than micro and small enterprises | 14 | 167.73 | 62.87 |
| (b) Short Term Provisions | 15 | 3.81 | 0.70 |
| (c) Other Current Liabilities | 16 | 1.86 | 6.29 |
| Current Liabilities | 203.3 | 70.7 | |
| Total Liabilities | 1620.02 | 516.96 |
| PARTICULARS | As at 31st March 2026 | As at Mar 31, 2025 |
|---|---|---|
| Audited | Audited | |
| A) CASH FLOW FROM OPERATING ACTIVITIES | ||
| Net Profit as per Profit & Loss A/c | 27.70 | (1.41) |
| Adjustment for: | ||
| – Depreciation | 0.40 | 0.64 |
| – Other comprehensive income | – | – |
| – Loss on Sale / Discard of Intangible Assets (Net) | – | 1.89 |
| Net Operating Profit Before Working Capital | 28.10 | 1.12 |
| Changes | ||
| Adjustment for: | ||
| – Trade & Other Receivables | (47.75) | (95.26) |
| – Changes in inventory | (94.13) | (5.75) |
| – Other Current Assets | (513.48) | (1.36) |
| – Trade Payables | 104.86 | 52.53 |
| – Other Financial liabilities | 0.96 | (10.82) |
| – Other current liabilities | (4.42) | (6.24) |
| – Provisions | 3.11 | 2.24 |
| – Other Financial Asset | (573.97) | (161.00) |
| Net Cash from Operating Activities | (1096.74) | (229.02) |
| Direct taxes paid | 2.87 | 0 |
| Net Cash from Operating Activities | (1099.61) | (229.02) |
| B) CASH FLOW FROM INVESTING ACTIVITIES | ||
| Purchase of Fixed Assets | – | – |
| Sale of Fixed assets | – | – |
| Net Cash from Investing Activities | – | – |
| C) CASH FLOW FROM FINANCING ACTIVITIES | ||
| Share application money pending allotment | 951.60 | 507.26 |
| Share Application money pending allotment money returned | -6.00 | |
| Proceeds from long/short term borrowings | 28.13 | (30.25) |
| Repayment of borrowings | ||
| Net Cash from Financing Activities | 973.73 | 477.01 |
| Net Increase in Cash & Cash Equivalents | (125.88) | 247.99 |
| Add: Opening Cash & Cash Equivalents | 248.24 | 0.25 |
| Cash and Cash equivalents at the end of the year | 122.36 | 248.24 |